Diabetes : intravitreous ranibizumab for proliferative diabetic retinopathy

Jonathan M. Gibson*, Samantha McGinnigle

*Corresponding author for this work

Research output: Contribution to journalLetter, comment or opinion

Abstract

The Diabetic Retinopathy Clinical Research Network has published the 2-year results of a 5-year study comparing intravitreous ranibizumab with panretinal laser photocoagulation in patients with proliferative diabetic retinopathy. The results suggest that intravitreous ranibizumab will become a valuable treatment option, although its exact role remains to be defined.
Original languageEnglish
Pages (from-to)130-131
Number of pages2
JournalNature Reviews Endocrinology
Volume12
Issue number3
DOIs
Publication statusPublished - 22 Jan 2016

Bibliographical note

-

Keywords

  • diabetes complications
  • drug therapy
  • eye diseases

Fingerprint Dive into the research topics of 'Diabetes : intravitreous ranibizumab for proliferative diabetic retinopathy'. Together they form a unique fingerprint.

  • Cite this